These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 15865883)
1. Update on the medical management of pituitary adenomas. Pickett CA Curr Neurol Neurosci Rep; 2005 May; 5(3):178-85. PubMed ID: 15865883 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of pituitary adenomas]. Mezosi E; Nemes O Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960 [TBL] [Abstract][Full Text] [Related]
3. [Novel pharmacologic therapies in acromegaly]. Góth M; Hubina E; Kovács L; Szabolcs I Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860 [TBL] [Abstract][Full Text] [Related]
4. New perspectives in the medical treatment of acromegaly. Colao A; Pivonello R; Auriemma RS; Galdiero M; Guerra E; Milone F; De Leo M; Lombardi G J Endocrinol Invest; 2005; 28(11 Suppl International):58-66. PubMed ID: 16625847 [TBL] [Abstract][Full Text] [Related]
5. Medical management of growth hormone-secreting pituitary adenomas. Racine MS; Barkan AL Pituitary; 2002; 5(2):67-76. PubMed ID: 12675503 [TBL] [Abstract][Full Text] [Related]
6. [New medical treatments in pituitary adenomas]. Drutel A; Caron P; Archambeaud F Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S16-28. PubMed ID: 18954854 [TBL] [Abstract][Full Text] [Related]
7. The treatment algorithm of acromegaly. Colao A; Pivonello R; Cappabianca P; Vitale G; Lombardi G J Endocrinol Invest; 2003; 26(8 Suppl):39-45. PubMed ID: 15233211 [No Abstract] [Full Text] [Related]
10. Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives. Cuny T; Barlier A; Feelders R; Weryha G; Hofland LJ; Ferone D; Gatto F Ann Endocrinol (Paris); 2015 Feb; 76(1):43-58. PubMed ID: 25556152 [TBL] [Abstract][Full Text] [Related]
11. Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours. Colao A; Filippella M; Pivonello R; Di Somma C; Faggiano A; Lombardi G Eur J Endocrinol; 2007 Apr; 156 Suppl 1():S57-S63. PubMed ID: 17413190 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological therapy for acromegaly: a critical review. Muller AF; Van Der Lely AJ Drugs; 2004; 64(16):1817-38. PubMed ID: 15301564 [TBL] [Abstract][Full Text] [Related]
13. Medical approach to pituitary tumors. Neggers SJ; van der Lely AJ Handb Clin Neurol; 2014; 124():303-16. PubMed ID: 25248595 [TBL] [Abstract][Full Text] [Related]
14. Medical therapy of pituitary adenomas: effects on tumor shrinkage. Colao A; Pivonello R; Di Somma C; Savastano S; Grasso LF; Lombardi G Rev Endocr Metab Disord; 2009 Jun; 10(2):111-23. PubMed ID: 18791829 [TBL] [Abstract][Full Text] [Related]
15. Somatostatin analogs in medical treatment of acromegaly. Racine MS; Barkan AL Endocrine; 2003 Apr; 20(3):271-8. PubMed ID: 12721507 [TBL] [Abstract][Full Text] [Related]
16. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas. Saveanu A; Jaquet P; Brue T; Barlier A Mol Cell Endocrinol; 2008 May; 286(1-2):206-13. PubMed ID: 18241980 [TBL] [Abstract][Full Text] [Related]
17. Management of endocrine disease: GH excess: diagnosis and medical therapy. Andersen M Eur J Endocrinol; 2014 Jan; 170(1):R31-41. PubMed ID: 24144967 [TBL] [Abstract][Full Text] [Related]
18. [Medical treatment of pituitary adenoma]. Chanson P Rev Prat; 1996 Jun; 46(12):1509-13. PubMed ID: 8881166 [TBL] [Abstract][Full Text] [Related]
19. Current pharmacotherapy for acromegaly: a review. Biermasz NR; Romijn JA; Pereira AM; Roelfsema F Expert Opin Pharmacother; 2005 Nov; 6(14):2393-405. PubMed ID: 16259571 [TBL] [Abstract][Full Text] [Related]
20. Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds. Zatelli MC; Ambrosio MR; Bondanelli M; Uberti ECD Eur J Endocrinol; 2007 Apr; 156 Suppl 1():S29-S35. PubMed ID: 17413185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]